Form 8-K - Current report:
SEC Accession No. 0001437749-25-021169
Filing Date
2025-06-24
Accepted
2025-06-24 16:34:45
Documents
13
Period of Report
2025-06-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dyai20250605_8k.htm   iXBRL 8-K 42621
  Complete submission text file 0001437749-25-021169.txt   173312

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dyai-20250620.xsd EX-101.SCH 3579
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20250620_def.xml EX-101.DEF 11424
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20250620_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20250620_pre.xml EX-101.PRE 11584
15 EXTRACTED XBRL INSTANCE DOCUMENT dyai20250605_8k_htm.xml XML 2845
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 251069677
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)